Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.
Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors PR Newswire BOSTON, Jan. 13, 2025 Collaboration...
Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire BOSTON, Jan. 9, 2025 BOSTON, Jan. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA...
Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program PR...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1694 | -1.57142857143 | 10.78 | 10.845 | 8.44 | 1276518 | 9.29055067 | CS |
4 | 2.1506 | 25.4208037825 | 8.46 | 12.75 | 8.4 | 1412282 | 10.06030963 | CS |
12 | 2.6206 | 32.7984981227 | 7.99 | 12.75 | 6.01 | 1311671 | 9.13242126 | CS |
26 | -3.8614 | -26.6818684356 | 14.472 | 16.392 | 5.26 | 9578848 | 11.47027856 | CS |
52 | -37.7894 | -78.0772727273 | 48.4 | 64.4 | 5.26 | 24788006 | 27.07036396 | CS |
156 | -213.7894 | -95.2715686275 | 224.4 | 255.2 | 5.26 | 22802200 | 69.65732366 | CS |
260 | -438.9894 | -97.6399911032 | 449.6 | 634.56 | 5.26 | 21426252 | 84.98477101 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관